密歇根州骨转移姑息放疗当代实践模式评估
研究提取密歇根州20家不同机构2017年1–2月各最近10例骨转移放疗病例,共196例纳入分析,识别出28种分割方案,最常见为3 Gy×10次(51.0%)、4 Gy×5次(16.3%)和8 Gy×1次(7.7%);在70例简单疼痛性骨转移中仅12.9%接受8 Gy×1次。
要点
- 196例骨转移放疗中识别出28种分割方案,3 Gy×10次占51.0%。
- 单次8 Gy放疗的显著预测因素为寡转移(P=.008)、既往重叠放疗(P=.050)和学术实践类型(P=.039)。
- 简单疼痛性骨转移(n=70)中仅12.9%接受8 Gy×1次治疗。
核心结论
- 骨转移代表异质性疾病,其放疗方式同样多样;未来需理解单次分割使用的障碍,并开展临床试验为这一复杂疾病的广泛情况建立适当指南。
研究设计与样本
- 密歇根州20家不同机构对其2017年1月至2月间最近10例骨转移放疗病例提取数据,共196例符合纳入标准,采用单变量和多变量二元逻辑回归评估单次分割(8 Gy×1)放疗的使用。
主要发现
- 共识别28种不同分割方案,最常见为3 Gy×10次(n=100;51.0%)、4 Gy×5次(n=32;16.3%)和8 Gy×1次(n=15;7.7%)。
- 单次分割放疗的显著预测因素为寡转移性疾病(P=.008)、既往重叠放疗(P=.050)和学术实践类型(P=.039)。
- 29例(14.8%)接受>10次分割(中位15次,范围11–20次)。
- 调强放疗用于14例(7.1%),立体定向体部放疗用于11例(5.6%),锥形束CT图像引导用于11例(5.6%)。
- 简单疼痛性骨转移(无既往手术、脊髓压迫、骨折、软组织延伸或重叠既往放疗;n=70)中仅12.9%接受8 Gy×1次治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Palliative radiation therapy for bone metastases is often viewed as a single entity, despite national guidelines providing input principally only for painful uncomplicated bone metastases. Data surrounding the treatment of bone metastases are often gleaned from questionnaires of what providers would theoretically do in practice or from population-based data lacking critical granular information. We investigated the real-world treatment of bone metastases with radiation therapy. METHODS AND MATERIALS: Twenty diverse institutions across the state of Michigan had data extracted for their 10 most recent cases of radiation therapy delivered for the treatment of bone metastases at their institution between January and February 2017. Uni- and multivariable binary logistic regression was used to assess the use of single fraction (8 Gy × 1) radiation therapy. RESULTS: A total of 196 cases were eligible for inclusion. Twenty-eight different fractionation schedules were identified. The most common schedule was 3 Gy × 10 fractions (n = 100; 51.0%), 4 Gy × 5 fractions (n = 32; 16.3%), and 8 Gy × 1 (n = 15; 7.7%). The significant predictors for the use of single fraction radiation therapy were the presence of oligometastatic disease (P = .008), previous overlapping radiation therapy (P = .050), and academic practice type (P = .039). Twenty-nine cases (14.8%) received >10 fractions (median 15, range 11-20). Intensity modulated radiation therapy was used in 14 cases (7.1%), stereotactic body radiation therapy in 11 (5.6%), and image guidance with cone beam computed tomography in 11 (5.6%). Of the cases of simple painful bone metastases (no previous surgery, spinal cord compression, fracture, soft tissue extension, or overlapping previous radiation therapy; n = 70), only 12.9% were treated with 8 Gy × 1. CONCLUSIONS: Bone metastases represent a heterogeneous disease, and radiation therapy for bone metastases is similarly diverse. Future work is needed to understand the barriers to single fraction use, and clinical trials are necessary to establish appropriate guidelines for the breadth of this complex disease.
引用
- Spratt DE, Mancini BR, Hayman JA, et al. Contemporary Statewide Practice Pattern Assessment of the Palliative Treatment of Bone Metastasis. Int J Radiat Oncol Biol Phys. 2018. PMID: 29726364. doi:10.1016/j.ijrobp.2018.02.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。